← All founder guides
ComplianceDay 12 · Founder Readiness Series

Regulatory Sandboxes in Nigeria: CBN vs SEC — When to Apply (and When Not To)

Sandbox programmes are not a licence substitute. Understand eligibility, limits, and exit paths.

Chimezie Chuta·20 July 2026·5 min read·Source: Fintech Law and Practice in Nigeria (Chapter 5 — Regulatory Sandboxes)

Regulatory sandboxes sound like a founder's dream — test your product in a controlled environment, with regulatory oversight, without full licensing. The reality in Nigeria is more nuanced. Sandboxes are innovation testing programmes, not licence substitutes.

Oturu's framework in Fintech Law and Practice in Nigeria helps founders distinguish when sandbox participation accelerates their path and when it creates false confidence.

What sandboxes actually are

Both CBN and SEC Nigeria operate sandbox or incubation programmes for financial innovation. These programmes allow selected participants to test products under regulatory supervision, typically with:

  • Limited customer numbers
  • Restricted transaction volumes
  • Heightened reporting requirements
  • Defined testing periods with exit criteria

What they are not: a path to avoid licensing, a permanent operating mode, or a guarantee of full authorisation after the testing period.

CBN sandbox vs SEC ARIP

FeatureCBN SandboxSEC ARIP
FocusPayment innovationDigital asset market entry
OutcomeProof of concept for licensingAIP → full registration pathway
Customer limitsImposed during testing10% growth cap during AIP
DurationFixed testing periodMulti-stage (months to years)
Solicitor requiredVariesYes — mandatory for formal application

For most digital asset founders, SEC ARIP is the relevant pathway — not a CBN sandbox. Payment-focused fintechs may find CBN's framework more applicable.

When to apply

Apply to a sandbox when:

  • Your product is genuinely novel with no clear licensing pathway yet
  • You need to demonstrate technical feasibility to regulators before formal application
  • You have a defined testing hypothesis with measurable outcomes
  • You understand the exit requirements (licensing, modification, or cessation)

Do not apply when:

  • Your product category is already clearly defined (DAX, DAOP, DAC have established registration processes)
  • You are using the sandbox to delay licensing you already know you need
  • You lack basic corporate infrastructure (incorporation, AML foundations)
  • You expect sandbox participation to substitute for ARIP or full registration

The exit problem

The most common sandbox mistake is no exit plan. Founders enter testing programmes without defining:

  • What success looks like (metrics, timeline, customer outcomes)
  • What licensing pathway follows a successful test
  • What happens if the test fails (pivot, wind-down, or restructure)
  • How customer obligations are fulfilled if registration is not achieved

SEC's ARIP Framework explicitly requires an exit plan in the operational plan — describing how customer obligations will be met if full registration is not achieved. This is not bureaucratic box-ticking. It is the question regulators and customers will ask.

How Klarify helps

  • FounderCounsel — ask about sandbox vs ARIP eligibility with cited regulatory context
  • ARIP Tracker — 5-stage workflow for SEC's Accelerated Regulatory Incubation Programme
  • Product Classifier — determines whether your product has a clear licensing path or needs exploratory engagement
  • Compliance Roadmap — Phase 3 ARIP application tasks

This is regulatory information and operational guidance — not legal advice. Sandbox and ARIP eligibility should be assessed with qualified regulatory counsel.


This article adapts themes from Chapter 5 of Fintech Law and Practice in Nigeria (Oturu). Klarify provides regulatory information, not legal advice. For advice specific to your situation, consult a qualified practitioner.

Take action with Klarify

Turn regulatory guidance into a structured readiness plan — classification, roadmap, and investor-ready documentation.

Klarify provides regulatory information, not legal advice. For advice specific to your situation, consult a qualified practitioner.